Antiplatelet therapy and long term risk after acute coronary syndrom

Organized with the participation of AstraZeneca

Jeudi 18 Janvier 2018   16:00-17:30   Maillot room
Symposium (organized with the participation of Industry)
16:00 • Tomas Jernberg
Antiplatelet treatment in real world: what should we remember?
16:20 • Marc Bonaca
The PEGASUS trial. High risk patient: why treating in the long term?
16:40 • François Schiele
How to optimize and coordinate the patient care?
16:55 • Gilles Lemesle
In clinical practice: how to do?
Panel discussion